Skip to main content

Cepheid Expands Smart Cycler Distribution Agreement with Fisher Scientific

NNEW YORK, Feb. 10 - Cepheid of Sunnyvale, Calif., has expanded a distribution agreement with Fisher Scientific for its Smart Cycler DNA sequence detection instrument, Cepheid said today.

 

Fisher will now have non-exclusive rights to distribute the Smart Cycler in the USlife science research, environmental, pharmaceutical quality control, IVF quality control, and cosmetics quality control markets, but will not have rights to distribute the instrument in the bio-threat market, the company said.

 

The agreement expires in May 2004. Previously, Fisher Scientific was the exclusive distributor of Cepheid Smart Cycler systems in the USlife science research market, above certain minimum purchase levels.

 

The agreement complements Cepheid's direct sales efforts in the USlife science markets, as well as its distributions agreements in Europewith Izasa SA and Bucher (Switzerland); and Diagnostic Technology Pty in Australiaand New Zealand.

 

Cepheid launched its SmartCycler II last December.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.